Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Patients With Acute Myeloid Leukemia”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT00763763
What this trial is testing

Imatinib Mesylate With Vincristine and Dexamethasone in Acute Lymphoblastic Leukemias With BCR-ABL Positive

Who this might be right for
Leukemia, Lymphocytic, AcutePhiladelphia ChromosomeBlast Crisis+1 more
Assistance Publique - Hôpitaux de Paris 55
Testing effectiveness (Phase 2)Ended earlyNCT01907815
What this trial is testing

Trametinib and Akt Inhibitor GSK2141795 in Treating Patients With Acute Myeloid Leukemia

Who this might be right for
Recurrent Adult Acute Myeloid LeukemiaUntreated Adult Acute Myeloid Leukemia
National Cancer Institute (NCI) 24
Testing effectiveness (Phase 2)Study completedNCT00590187
What this trial is testing

Efficacy Study of Oral Sapacitabine to Treat Acute Myeloid Leukemia in Elderly Patients

Who this might be right for
Acute Myeloid Leukemia
Cyclacel Pharmaceuticals, Inc. 105
Testing effectiveness (Phase 2)Ended earlyNCT03724084
What this trial is testing

Pinometostat With Standard Chemotherapy in Treating Patients With Newly Diagnosed Acute Myeloid Leukemia and MLL Gene Rearrangement

Who this might be right for
Acute Myeloid Leukemia
National Cancer Institute (NCI) 6
Early research (Phase 1)Active Not RecruitingNCT07094464
What this trial is testing

Maintenance Therapy With Selinexor and Azacitidine in TP53 Mutant AML/MDS After Transplantation

Who this might be right for
TP53-mutated MDS and AMLAllogeneic Hematopoietic Stem Cell Transplantation
Daihong Liu 20
Not applicableEnded earlyNCT00658411
What this trial is testing

Deferoxamine for Iron Overload Before Allogeneic Stem Cell Transplantation

Who this might be right for
Acute Myeloid LeukemiaAcute Lymphoblastic LeukemiaMyelodysplastic Syndrome
Dana-Farber Cancer Institute 5
Early research (Phase 1)Study completedNCT00004871
What this trial is testing

Azacitidine Plus Phenylbutyrate in Treating Patients With Acute Myeloid Leukemia or Myelodysplastic Syndrome

Who this might be right for
LeukemiaMyelodysplastic SyndromesMyelodysplastic/Myeloproliferative Diseases
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Testing effectiveness (Phase 2)Looking for participantsNCT04493164
What this trial is testing

CPX-351 and Ivosidenib for the Treatment of IDH1 Mutated Acute Myeloid Leukemia or High-Risk Myelodysplastic Syndrome

Who this might be right for
Acute Myeloid Leukemia With Gene MutationsMyelodysplastic SyndromeMyeloproliferative Neoplasm+2 more
M.D. Anderson Cancer Center 30
Testing effectiveness (Phase 2)Study completedNCT00003408
What this trial is testing

Biological Therapy Following Chemotherapy and Peripheral Stem Cell Transplantation in Treating Patients With Cancer

Who this might be right for
Breast CancerChronic Myeloproliferative DisordersGestational Trophoblastic Tumor+9 more
Cancer Treatment Centers of America 40
Not applicableEnded earlyNCT00255684
What this trial is testing

Fludarabine, Cyclophosphamide, and Total-Body Irradiation Followed by Cyclosporine and Mycophenolate Mofetil in Treating Patients Who Are Undergoing a Donor Umbilical Cord Blood Transplant for Hematologic Cancer

Who this might be right for
Chronic Myeloproliferative DisordersGraft Versus Host DiseaseLeukemia+4 more
University of Rochester 16
Testing effectiveness (Phase 2)Ended earlyNCT00719849
What this trial is testing

Donor Umbilical Cord Blood Transplant in Treating Patients With Advanced Hematological Cancer or Other Disease

Who this might be right for
LeukemiaLymphomaMultiple Myeloma and Plasma Cell Neoplasm+2 more
Fred Hutchinson Cancer Center 13
Early research (Phase 1)Not Yet RecruitingNCT07131085
What this trial is testing

QH101 Cell Therapy Relapsed/Refractory(R/R) Acute Myeloid Leukemia(AML) and Myelodysplastic Syndromes(MDS)

Who this might be right for
MDSAML
Anhui Provincial Hospital 9
Testing effectiveness (Phase 2)Study completedNCT01435343
What this trial is testing

Treatment of Relapsed or Refractory Acute Myeloblastic Leukemia

Who this might be right for
Acute Myeloblastic Leukemia
PETHEMA Foundation 55
Testing effectiveness (Phase 2)Looking for participantsNCT06424340
What this trial is testing

MB-dNPM1-TCR.1 in Relapsed/Refractory AML

Who this might be right for
Leukemia, Myeloid, Acute
Miltenyi Biomedicine GmbH 29
Early research (Phase 1)Looking for participantsNCT06820268
What this trial is testing

XS-04 in Patients With Relapsed or Refractory Hematologic Malignancies

Who this might be right for
B-cell LymphomaAcute Myeloid LeukemiaMyelodysplastic Syndrome
Shanghai Fosun Pharmaceutical Industrial Development Co. Ltd. 168
Testing effectiveness (Phase 2)Study completedNCT00789776
What this trial is testing

Fludarabine Phosphate, Cyclophosphamide, Total-Body Irradiation, and Donor Bone Marrow Transplant Followed by Donor Natural Killer Cell Therapy, Mycophenolate Mofetil, and Tacrolimus in Treating Patients With Hematologic Cancer

Who this might be right for
Acute Lymphoblastic LeukemiaAcute Myeloid LeukemiaAggressive Non-Hodgkin Lymphoma+13 more
Fred Hutchinson Cancer Center 41
Early research (Phase 1)Study completedNCT00981240
What this trial is testing

Dose Escalation, Safety and Pharmacokinetic Study of SAR103168 in Patients Refractory/ Relapsed Acute Leukemias or High-risk Myelodysplastic Syndromes

Who this might be right for
Acute Myelogenous Leukemia
Sanofi 30
Testing effectiveness (Phase 2)Study completedNCT01420926
What this trial is testing

Decitabine With or Without Bortezomib in Treating Older Patients With Acute Myeloid Leukemia

Who this might be right for
Acute Myeloid LeukemiaAcute Myeloid Leukemia Arising From Previous Myelodysplastic SyndromeTherapy-Related Acute Myeloid Leukemia
National Cancer Institute (NCI) 165
Testing effectiveness (Phase 2)Study completedNCT01786343
What this trial is testing

Decitabine for Older or Unfit Patients With Acute Myeloid Leukemia (AML)

Who this might be right for
Leukemia
M.D. Anderson Cancer Center 74
Testing effectiveness (Phase 2)Ended earlyNCT00871689
What this trial is testing

Chemotherapy, Total-Body Irradiation, Donor Natural Killer Cell Infusion, Aldesleukin, and UCB Transplant in Treating Patients With Relapsed or Refractory AML

Who this might be right for
Leukemia
Masonic Cancer Center, University of Minnesota 2
Next Page